Genome‐wide identification of pseudogenes capable of disease‐causing gene conversion

Pseudogenes are remnants of gene duplication (nonprocessed pseudogenes) and retrotransposition (processed pseudogenes) events. This study describes methods for identifying gene conversion candidates from predicted pseudogenes. Pseudogenes may accumulate and harbor sequence variations over time that become disease‐causing mutations when transferred to genes by gene conversion. A total of 14,476 pseudogenes were identified, including 3,426 nonprocessed pseudogenes. In addition, 1,945 nonprocessed pseudogenes that are localized near their progenitor gene were evaluated for their possible role in gene conversion and disease. All 11 known, human cases of gene conversion (with deleterious effects) involving pseudogenes were successfully identified by these methods. Among the pseudogenes identified is a retinitis pigmentosa 9 (RP9) pseudogene that carries a c.509A>G mutation which produces a p.Asp170Gly substitution that is associated with the RP9 form of autosomal dominant retinitis pigmentosa (adRP). The c.509A>G mutation in RP9 is a previously unrecognized example of gene conversion between the progenitor gene and its pseudogene. Notably, two processed pseudogenes also contain mutations associated with diseases. An inosine monophosphate dehydrogenase 1 (IMPDH1) pseudogene carries a c.676G>A mutation that produces a p.Asp226Asn substitution that causes the retinitis pigmentosa 10 (RP10) form of adRP; and a phosphoglycerate kinase 1 (PGK1) pseudogene (PGK1P1) carries a c.837T>C mutation that produces a p.Ile252Thr substitution that is associated with a phosphoglycerate kinase deficiency. Ranking of nonprocessed pseudogenes as candidates for gene conversion was also performed based on the sequence characteristics of published cases of pseudogene‐mediated gene conversion. All results and tools produced by this study are available for download at: http://genome.uiowa.edu/pseudogenes. Hum Mutat 27(6), 545–552, 2006. © 2006 Wiley‐Liss, Inc.

[1]  F. Ayala,et al.  The β-esterase Gene Cluster of Drosophila melanogaster: is ψEst-6 a Pseudogene, a Functional Gene, or both? , 2004, Genetica.

[2]  Terrence S. Furey,et al.  The UCSC Genome Browser Database , 2003, Nucleic Acids Res..

[3]  B. Dworniczak,et al.  Homologues to the first gene for autosomal dominant polycystic kidney disease are pseudogenes. , 2001, Genomics.

[4]  Jo McEntyre,et al.  The NCBI Handbook , 2002 .

[5]  F. Hill,et al.  Homozygous gene conversion in von Willebrand factor gene as a cause of type 3 von Willebrand disease and predisposition to inhibitor development. , 2001, Blood.

[6]  K. Sperling,et al.  A unique form of autosomal dominant cataract explained by gene conversion between β-crystallin B2 and its pseudogene , 2001, Journal of medical genetics.

[7]  G. Batist,et al.  Connexin43 pseudogene is expressed in tumor cells and inhibits growth , 2004, Oncogene.

[8]  Y. Satta,et al.  Frequent segmental sequence exchanges and rapid gene duplication characterize the MHC class I genes in lemurs , 2003, Immunogenetics.

[9]  Y. Makita,et al.  Novel SBDS mutations caused by gene conversion in Japanese patients with Shwachman-Diamond syndrome , 2004, Human Genetics.

[10]  M. Hims,et al.  Mutations in a protein target of the Pim-1 kinase associated with the RP9 form of autosomal dominant retinitis pigmentosa , 2002, European Journal of Human Genetics.

[11]  Sarah A Tishkoff,et al.  Signatures of selection and gene conversion associated with human color vision variation. , 2004, American journal of human genetics.

[12]  Mouchiroud Dominique,et al.  HOPPSIGEN: a database of human and mouse processed pseudogenes , 2004, Nucleic Acids Research.

[13]  H. Arakawa,et al.  Immunoglobulin gene conversion: Insights from bursal B cells and the DT40 cell line , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[14]  Seth Blackshaw,et al.  Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa. , 2002, Human molecular genetics.

[15]  L. Duret,et al.  GC-content evolution in mammalian genomes: the biased gene conversion hypothesis. , 2001, Genetics.

[16]  S. Chanock,et al.  Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease. , 2000, Blood.

[17]  Sequence variability of a human pseudogene. , 2001, Genome research.

[18]  P. Stenson,et al.  Human Gene Mutation Database (HGMD®): 2003 update , 2003, Human mutation.

[19]  M. L. Le Beau,et al.  Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction. , 1991, Biochemistry.

[20]  Yoshiyuki Sakaki,et al.  Whole-genome screening indicates a possible burst of formation of processed pseudogenes and Alu repeats by particular L1 subfamilies in ancestral primates , 2003, Genome Biology.

[21]  N. Galtier.  Gene conversion drives GC content evolution in mammalian histones. , 2003, Trends in genetics : TIG.

[22]  M S Meselson,et al.  A general model for genetic recombination. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. O'Shea,et al.  Neuronal Expression of Neural Nitric Oxide Synthase (nNOS) Protein Is Suppressed by an Antisense RNA Transcribed from an NOS Pseudogene , 1999, The Journal of Neuroscience.

[24]  A. Griffiths.  Introduction to Genetic Analysis , 1976 .

[25]  J. Lupski,et al.  Molecular mechanisms for genomic disorders. , 2003, Annual review of genomics and human genetics.

[26]  Alan F. Scott,et al.  Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2004, Nucleic Acids Res..

[27]  G. Germino,et al.  Gene conversion is a likely cause of mutation in PKD1. , 1998, Human molecular genetics.

[28]  Atsushi Yoshiki,et al.  An expressed pseudogene regulates the messenger-RNA stability of its homologous coding gene , 2003, Nature.

[29]  T. Fukuda,et al.  A Novel Missense Mutation (837T→C) in the Phosphoglycerate Kinase Gene of a Patient With a Myopathic Form of Phosphoglycerate Kinase Deficiency , 1998, Journal of child neurology.

[30]  M. Gerstein,et al.  Large-scale analysis of pseudogenes in the human genome. , 2004, Current opinion in genetics & development.

[31]  A. Lumsden,et al.  A novel Q378X mutation exists in the transmembrane transporter protein ABCC6 and its pseudogene: implications for mutation analysis in pseudoxanthoma elasticum , 2001, Journal of Molecular Medicine.

[32]  M. Bondeson,et al.  Homologous nonallelic recombinations between the iduronate-sulfatase gene and pseudogene cause various intragenic deletions and inversions in patients with mucopolysaccharidosis type II , 1998, European Journal of Human Genetics.

[33]  B. Blomberg,et al.  Physical location of the human immunoglobulin lambda-like genes, 14.1, 16.1, and 16.2 , 1993, Immunogenetics.

[34]  R. Finnell,et al.  Folate pathway gene alterations in patients with neural tube defects. , 2000, American journal of medical genetics.

[35]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[36]  E. Sidransky,et al.  Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease , 2000, Human mutation.

[37]  D. Niu,et al.  Structural analysis of the chimeric CYP21P/CYP21 gene in steroid 21-hydroxylase deficiency , 2002, Journal of Human Genetics.

[38]  D. Campana,et al.  Mutations in the Human λ5/14.1 Gene Result in B Cell Deficiency and Agammaglobulinemia , 1998, The Journal of experimental medicine.